Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT1806 (Tofidence) vs RoActemra in RA
NCT03830203Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Dec 2018
- Primary completion
- Jan 2021
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Bio-Thera Solutions, Ltd.. Started Dec 2018; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03830203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830203.